JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 50 filers reported holding JUNIPER PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $83,000 | -44.7% | 16,490 | -47.8% | 0.03% | -32.7% |
| Q1 2017 | $150,000 | +57.9% | 31,619 | +87.0% | 0.05% | +96.0% |
| Q4 2016 | $95,000 | +15.9% | 16,912 | +15.0% | 0.02% | +25.0% |
| Q3 2016 | $82,000 | -77.0% | 14,707 | -57.5% | 0.02% | -47.4% |
| Q4 2015 | $356,000 | -69.7% | 34,611 | -65.3% | 0.04% | -66.4% |
| Q3 2015 | $1,176,000 | – | 99,823 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 481,459 | $5,672,000 | 2.05% |
| Krensavage Asset Management, LLC | 279,717 | $3,295,000 | 1.19% |
| EAM Investors, LLC | 145,898 | $1,719,000 | 0.27% |
| PERRITT CAPITAL MANAGEMENT INC | 93,000 | $1,096,000 | 0.23% |
| TFS CAPITAL LLC | 99,823 | $1,176,000 | 0.11% |
| Bellevue Asset Management AG | 50,000 | $589,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 88,232 | $1,039,000 | 0.07% |
| Spark Investment Management LLC | 39,200 | $461,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 100,564 | $1,185,000 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 35,599 | $419,000 | 0.03% |